WayPoint Biomedical Holdings, Inc. (OTCPK: WYPH)
Health Care · Health Care Equipment & Supplies · US
$0.00
— today · +400.0% 1Y
WayPoint Biomedical Holdings, Inc. (OTCPK: WYPH) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $27.80K and employs 1 people.
Over the last twelve months the share price has gained 400.0%, trading between 0.00 and 0.00.
Tweenvest scores WayPoint Biomedical Holdings, Inc. across four factors: value 78/100. Its strongest factor is value.
WYPH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $27.80K
- Revenue (TTM)
- $33.24K
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- -83.11
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 55.60M
- Employees
- 1
- Next earnings
- —
About WayPoint Biomedical Holdings, Inc.
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction. In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.
- ISIN
- US9467552041
- Founded
- 2004
- Listed since
- Apr 6, 2015
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | +2.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.81 | +1.19% |
| Stryker CorporationNYSE: SYK | $126.37B | $329.45 | +0.53% |
| Medtronic plcNYSE: MDT | $119.49B | $93.35 | +1.14% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €163.20 | +1.24% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.37 | +2.03% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.